Pdt Partners, LLC Solid Biosciences Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.08 - $7.79 $126,896 - $320,948	-41,200 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.08 $4,242 - $6,468	-2,100 Reduced 4.85%	41,200 $84,000
Q2 2020 Aug 14, 2020	SELL	$2.1 - $3.42 $123,242 - $200,709	-58,687 Reduced 57.54%	43,300 $127,000
Q1 2020 May 15, 2020	SELL	$2.31 - $4.43 $40,887 - $78,411	-17,700 Reduced 14.79%	101,987 $244,000
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $165,779 - $758,352	58,787 Added 96.53%	119,687 $533,000

Q3 2019 Nov 14, 2019	SELL	$4.33 - $11.64 $226,892 - $609,936	-52,400 Reduced 46.25%	60,900 $630,000
Q2 2019 Aug 14, 2019	BUY	$4.6 - $10.13 $521,179 - $1.15 Million	113,300 New	113,300 $651,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $44.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.